Esranur Aydın: Presenting AI-Powered Molecular Tumor Board Curation at ESMO AI and Digital Oncology 2026
Esranur Aydın/LinkedIn

Esranur Aydın: Presenting AI-Powered Molecular Tumor Board Curation at ESMO AI and Digital Oncology 2026

Esranur Aydın, Clinical Cancer Scientist at Medicana Health Group, shared on LinkedIn:

“Bringing multiple posters to one congress sounds efficient. Then the session opens and you remember you can only be in one place at a time!

At ESMO – European Society for Medical Oncology AI and Digital Oncology 2026 in Berlin we presented 173P and 222P, and the conversations at our boards barely paused.

What we showed, in short: ten years of molecular tumor board experience doesn’t have to stay inside one hospital. With MDT, a physician uploads a patient’s CGP report and gets a curated interpretation built on our MTB history and the literature, with an expert always in the loop. Not just the ESCAT Tier I–II matches, but the options that usually surface only when the right people are in the room.

Esranur Aydın: Presenting AI-Powered Molecular Tumor Board Curation at ESMO AI and Digital Oncology 2026

That idea seemed to land. Which was nice, because we genuinely believe it.

Thank you to everyone who stopped by, pushed back and asked the hard questions. Several of you are now in my inbox already and if we missed each other in Berlin, my DMs are always open!

As always, a big shout-out to my team Eylül Özgü, Şevval Nur Bilgiç, PhD, Ünal Metin Tokat, Fikri Mert Altınay, MSc., Zeynep Sakaoglu, Dr. Ashkan Adibi and Murat Demir.
A very special thank you to Prof. Dr. Mutlu Demiray for the mentorship behind all of this and to Ebru Karakoç for her support through the event.

And this time a shout out is also going to our Amazon Web Services (AWS) co-authors Orkun Torun and Yigit Kizilyaprak as well!

Our first but definitely not last collaboration.”

You may also be interested in:

Neel Parikh: A Random Uber Conversation, a Poster at ESMO, and Memories from Madrid

AI in Oncology: Do We Have a Vision, or Are We Doomed?

Esranur Aydın: Presenting AI-Powered Molecular Tumor Board Curation at ESMO AI and Digital Oncology 2026